跳至主要内容
临床试验/DRKS00034342
DRKS00034342
已完成
不适用

The role of genetic polymorphisms in the CNS transport of endogenous metabolites and drugs in intensive care medicine. - CSFGENE

niversitätsmedizin Göttingen, Institut für klinische Pharmakologie0 个研究点目标入组 100 人2024年5月29日

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
未指定
发起方
niversitätsmedizin Göttingen, Institut für klinische Pharmakologie
入组人数
100
状态
已完成
最后更新
去年

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2024年5月29日
结束日期
待定
最后更新
去年
研究类型
Observational
性别
All

研究者

发起方
niversitätsmedizin Göttingen, Institut für klinische Pharmakologie

入排标准

入选标准

  • 1\. Intensive care patients who have received an external cerebrospinal fluid drainage (EVD or LD) due to acute brain injury.
  • 2\. Consent from the patient or their legal representative. If a legal representative is not available at the time of study inclusion, inclusion can be carried out under the assumption of presumed will due to the minimal risk and minimal burden of the study\-related measures. As soon as the patient is responsive again or a guardian or healthcare proxy is available, they will be asked for consent. If consent is denied, the data and biomaterials of the affected patient will not be used further.

排除标准

  • 1\. Exclusively palliative treatment due to a poor prognosis, expected survival \< 48 hours.
  • 2\. Refusal to participate in the study by the patient or by the guardian.
  • 3\. Refusal of intensive medical care.

结局指标

主要结局

未指定

相似试验